Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
NYSE:PHR
Holding PHR?
Track your performance easily
PHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$14.55 - $29.16
Previous Close$18.55
Volume650.88K
Average Volume (3M)404.14K
Market Cap
$1.07B
Enterprise Value$1.01B
Total Cash (Recent Filing)$81.80M
Total Debt (Recent Filing)$16.52M
Price to Earnings (P/E)―
Beta2.41
Next Earnings
Dec 09, 2024EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding57,773,275
10 Day Avg. Volume485,632
30 Day Avg. Volume404,138
Standard Deviation0.16
R-Squared0.09
Alpha-0.00593
Financial Highlights & Ratios
Price to Book (P/B)4.26
Price to Sales (P/S)2.75
Price to Cash Flow (P/CF)24.20
P/FCF Ratio73.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.58
Enterprise Value/Gross Profit4.33
Enterprise Value/Ebitda-14.94
Forecast
1Y Price Target
$29.78Price Target Upside60.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Phreesia News
PremiumThe Fly
Phreesia falls -17.3%
PremiumThe Fly
Phreesia falls -10.9%
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal revenue increased 19% YoY, driven by strong performance across different segments.
Growth PotentialManagement shared that average deal sizes in the pipeline are up ~20% YoY, indicating future growth potential.
Market PositionPhreesia has a strong market position, and, in our opinion, is a leading brand as evidenced by the company facilitating >150M visits, or >10% of patient visits in the U.S. in FY24.
Bears Say
Growth UncertaintyPhreesia trades at a CY25E EV/revenue multiple of 2.7x, which is justified by uncertainty surrounding the growth profile of the business beyond FY25.
Market PerceptionDespite an upward bias to 2Q revenue and adjusted EBITDA, a corresponding guidance raise is not expected, which could be viewed unfavorably by the market.
Operational PerformanceThe company expects to add roughly 100 AHSCs in 2Q, marking the lowest number of AHSC adds sequentially since 2QFY'22.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $14.54 and its highest was $29.16 in the past 12 months.
What is Phreesia’s market cap?
Currently, no data Available
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Dec 09, 2024 which is in 16 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on Sep 04, 2024. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.354 by $0.044.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is -$0.27.
How many shares outstanding does Phreesia have?
Phreesia has 57,773,273 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.354. Following the earnings report the stock price went up 6.289%.
Which hedge fund is a major shareholder of Phreesia?
Among the largest hedge funds holding Phreesia’s share is Deerfield Management Company, LP. It holds Phreesia’s shares valued at 4M.
---
Phreesia Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.78 (60.80% Upside)
$29.78 (60.80% Upside)
Blogger Sentiment
Bullish
PHR Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 6.5%
Last 30 Days ▲ 6.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.07%
12-Months-Change
Fundamentals
Return on Equity
-40.26%
Trailing 12-Months
Asset Growth
6.40%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
---
PHR Company Deck
---
PHR Earnings Call
Q2 2024
0:00 / 0:00
---
PHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
---
PHR Stock 12 Month Forecast
Average Price Target
$29.78
▲(60.80% Upside)
Technical Analysis
Best Analysts Covering PHR
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
-10.82%
reiterated a buy rating 3 months ago
Copying Anne Samuel's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -10.82% per trade.
---